RECRUITING

Breast Cancer Screening Adherence for Women at Moderate Risk for Breast Cancer

Talk to us

Conditions

Breast Carcinoma

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study assesses breast cancer screening adherence for women at moderately increased risk for developing breast cancer based on gene mutation status or empiric risk model estimates. It also seeks to determine facilitators and barriers to screening.

Official Title

Breast Cancer Screening Adherence for Women at Moderate Risk for Breast Cancer

Quick Facts

Study Start:2025-06-02
Study Completion:2028-06-02
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT07076147

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:30 Years to 75 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * \* \>= 30 years
  2. * =\< 75 years
  3. * Women with either:
  4. * Genetic test results showing moderately increased breast cancer risk due to a pathogenic/likely pathogenic variant in ATM, CHEK2, BARD1, RAD51C, or RAD51D (Mutation carrier group) OR
  5. * Calculated lifetime breast cancer risk estimates between 20% and 40% according to the Tyrer-Cuzick V8.0B empiric risk model (Empiric risk group)
  6. * Patients provided breast cancer risk assessments by genetic counselors at USC Norris or LA General Hospital beginning in 2021 and at least 12 months ago
  7. * Women recommended to undergo annual breast MRI and/or annual mammogram beginning at the time of their genetic counseling risk assessment
  8. * English or Spanish speaking patients
  1. * \* History of breast cancer before genetic counseling at University of Southern California (USC)
  2. * Any metastatic cancer diagnosis at time of genetic counseling risk assessment
  3. * Deceased
  4. * Patient underwent a risk reducing mastectomy before their genetic counseling risk assessment

Contacts and Locations

Principal Investigator

Jacob Comeaux
PRINCIPAL_INVESTIGATOR
University of Southern California

Study Locations (Sites)

Los Angeles General Medical Center
Los Angeles, California, 90033
United States
USC / Norris Comprehensive Cancer Center
Los Angeles, California, 90033
United States

Collaborators and Investigators

Sponsor: University of Southern California

  • Jacob Comeaux, PRINCIPAL_INVESTIGATOR, University of Southern California

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-06-02
Study Completion Date2028-06-02

Study Record Updates

Study Start Date2025-06-02
Study Completion Date2028-06-02

Terms related to this study

Additional Relevant MeSH Terms

  • Breast Carcinoma